A PHASE I STUDY OF KAN-004 IN PATIENTS WITH IMMUNE-RELATED DIARRHEA OR COLITIS

Registry ID

AE-KAN-004

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL

Start date

2026-03-19

Last update

2026-01-05

Conditions

• DIARRHEA
• IMMUNE-RELATED COLITIS

Related clinical trials

• PROPHYLACTIC ORAL MESALAMINE FOR THE PREVENTION OF IMMUNE-RELATED COLITIS IN PATIENTS TREATED WITH IPILIMUMAB/NIVOLUMAB

View on source registry